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Abstract
The accumulation of dysfunctional or damaged 
mitochondria in neurons has been linked to the 
pathogenesis of many neurodegenerative diseases, 
including Parkinson’s disease. It has been 
proposed that the Parkinson’s-related proteins 
PINK1 and Parkin regulate mitochondrial quality 
control by selectively targeting depolarized 
mitochondria for autophagic degradation, a 
process known as mitophagy. The 
compartmentalization of mitochondrial turnover 
in neurons still remains unclear, but evidence 
suggests that mitochondria are locally degraded in 
the distal axon and perhaps in the neuromuscular 
junctions (NMJs). To study this, intact Drosophila 
nervous systems were analyzed in vivo by 
performing gentle dissections on third instar 
larvae to expose the ventral ganglia and segmental 
nerves with their NMJs. Both control larvae and 
parkin mutants (parkin25) were genetically 
modifi ed to mark mitochondria via mitoGFP 
expression in their motor neurons, with park25 
being additionally modifi ed by deletion of the 
parkin gene. The physiological states of 
mitochondria were quantifi ed through 
measurements of mitochondrial membrane 
potential ( ), and the density of mitochondria in 
NMJs were analyzed through comparing αHRP 
and mitoGFP stain intensities in synaptic boutons. 
Unexpectedly, parkin25 mitochondria displayed 
normal  readings in NMJs, indicating that 
mutant nerve terminals do not accumulate 
senescent mitochondria. In addition, reduced 
mitochondrial density was observed in synaptic 
boutons of parkin25 animals. These results argue 
against the hypothesis that loss of Parkin results in 
the accumulation of depolarized mitochondria, 
instead suggesting a reduction of organelle density 
in synaptic boutons as a result of Parkin 
defi ciency. By elucidating the role of Parkin in the 
synapse of neurons, the pathogenic mechanism of 
Parkinson’s and other neurodegenerative diseases 
will be better understood.
Keywords
Parkin, mitophagy, mitochondrial turnover, 
mitochondrial membrane potential, Drosophila, 
synaptic bouton, neuromuscular junction
INTRODUCTION
Health of neurons depends critically on the 
function of their mitochondria, which mediate ATP 
production, cytosolic calcium homeostasis, and 
apoptosis. This is most evident in the manifestation 
of neurodegenerative diseases due to mitochondrial 
dysfunction (Shidara & Hollenbeck, 2010). 
Mitochondria exhibit a complex life cycle that is 
characterized, in part, by morphological changes 
through fi ssion and fusion (Okamoto & Shaw, 2005) 
and turnover through autophagic degradation, known 
as mitophagy (Rubinsztein et al., 2012; Terman et 
al., 2010). The regulation and performance of these 
life cycle features in a systematic order, known 
as mitochondrial quality control, is essential for 
proper maintenance of mitochondrial integrity 
and neuronal health (Devireddy et al., 2015). Due 
to the large and asymmetric structure of neurons, 
the compartmentalization and mechanisms of 
mitochondrial quality control within neurons remain 
poorly understood. The encoding of mitochondrial 
proteins in the nuclear genome and presence of 
lysosomal compartments suggests that the cell body 
is the major location for mitochondrial turnover. 
And evidence also suggests that these processes may 
occur in the axons (Amiri & Hollenbeck, 2008). 
However, it is unknown whether mitochondrial 
turnover occurs in the nerve terminals.
It has been proposed that two Parkinson’s disease-
related proteins, PTEN-induced putative kinase 1 
(PINK1) and the E3 ubiquitin ligase Parkin, 
regulate mitochondrial quality control (Narendra 
et al., 2012). Recent studies postulate three possible 
functions for the PINK1/Parkin pathway: tagging of 
dysfunctional mitochondria for mitophagy (Geisler 
et al., 2010), prevention of fusion between senescent 
and healthy mitochondria (Yang et al., 2008), and 
the arrest of mitochondrial motility to facilitate their 
degradation (Wang et al., 2011). Figure 1 outlines the 
proposed process of mitophagy. Though the precise 
mechanisms are not fully understood, it is believed 
that PINK1 is fi rst translocated to the surface of 
dysfunctional, depolarized mitochondria (Verburg 
and Hollenbeck, 2008); PINK1 then recruits 
Parkin to the mitochondrial membrane, which tags 
the mitochondrion with ubiquitin, marking it for 
mitophagy (Jin & Youle, 2012). Parkin then mediates 
the mitochondria’s engulfment via autophagosomes 
and its subsequent degradation.
In this study, we tested the widely held hypothesis 
that mitochondria in NMJs of parkin25 will exhibit 
defi cient  states and increased mitochondrial 
density in synaptic boutons. Since previous studies 
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have shown that mitophagy occurs primarily in the 
cell body (CB), we proposed that there is a 
“barrier” between the CB and axon, which allows 
only healthy mitochondria to pass through. If this 
holds true, it is believed that mitochondria in the 
synapses exhibit normal conditions rather than 
varying membrane potential states. To quantify  
states of mitochondria, a mitochondrial-to-
cytoplasmic TMRM dye fl uorescence ratio ( ) 
was measured in various mitochondria within 
synaptic boutons of NMJs. A mean measurement 
per sample was found, and a mean of means was 
calculated to compare the  ratio between control 
and parkin25 animals. We found that, unexpectedly, 
there was no signifi cant difference between the  
states of mitochondria from control and mutants, 
indicating that the physiological states of 
mitochondria in NMJs are seemingly independent 
of Parkin. Furthermore, Parkin mutants show 
reduced mitochondrial density in nerve terminals, 
suggesting that senescent mitochondria do not 
accumulate in neurons.
MATERIALS AND METHODS
Drosophila lines. All fl y stocks were maintained on 
standard cornmeal agar medium with 12-hour light/
dark cycles at 25° C. Two fl y sets, with a wild type 
control and parkin25 mutant line, were used for the 
mitochondrial  and density data. The wild type 
control fl y line was (W; +/+; D42 > UAS-
mitoGFP/+) and park25 line was (W; +/+; park25, 
D42-Gal4/park25, UAS-mitoGFP). To visualize 
mitochondria with green fl uorescent protein 
(mitoGFP) in the motor neurons, the GAL4-UAS 
system was used. In this system, the GAL4 protein 
is driven by D42 promoter to bind to the central 
control region UAS, located upstream from the 
inserted mitoGFP gene. This activates gene 
transcription of mitochondria with GFP specifi cally 
in motor neurons. 
Larval dissection for live confocal imaging. 
To observe Drosophila nervous systems in vivo, late 
third instar larvae were collected, dissected, and 
prepared following previously described methods 
(Devireddy et al., 2014). Refer to Figure 2 for the 
step-by-step method of dissection. Larvae were 
pinned down and longitudinally incised along their 
dorsal sides in HL6 buffer, which contains 0.6 
mM CaCl2 and 4 mM L-glutamate. Fat bodies and 
intestines were gently removed, and larval body 
walls were slightly pushed back to reveal the ventral 
ganglion (VG) and intact segmental nerves (SNs) 
with NMJs. The dissected larva was transferred to 
a glass slide, covered with a glass coverslip using 
double-sided tape as a spacer, and fi lled with HL6 
buffer before being sealed with VALAP wax on all 
sides to form a chamber. Mitochondria were imaged 
in distal axons, synapses, and NMJs of motor neurons 
using the Nikon C-1 laser scanning confocal system 
(LSCM) mounted on an Eclipse 90i microscope, and 
analysis was conducted with EZ-C1 and Elements 
software (Figure 3). The entire dissection and 
imaging procedure was completed within 25 minutes 
to ensure normal physiological in vivo conditions. 
Measurement of mitochondrial inner membrane 
potential ( ). To quantify membrane potential, 
images from the NMJs of control and park25 were 
taken between muscles 6 and 7 (M6–7). Samples 
were fi xed with a red tetramethylrhodamine methyl 
ester (TMRM, Life Technologies Molecular Probes; 
Cat. No. T668) stain for 20 minutes before imaging. 
The dye does not penetrate well into SNs, but it does 
equilibrate into the larval body wall. Therefore,  
of samples was estimated by comparing a 
mitochondrial-to-cytoplasmic dye fl uorescence ratio 
of TMRM signal intensity ( ). One hundred 
ninety-seven mitochondria from 13 control animals 
and 159 mitochondria from 12 mutant animals were 
analyzed in the thin axons adjacent to A4 SNs. The 
mean  ratio was calculated per animal, and a 
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mean of means was calculated per control and park25 
animal.  is determined by subtracting and 
thresholding the background to determine the mean 
mitochondrial fl uorescent intensity using the 
Elements software.  is determined by using two 
hand-drawn regions of ~0.5  to fi nd the mean 
signal intensity of the two boxes in the cytoplasmic 
region. The mean is taken as the  of that particular 
mitochondrion. The  ratio has a logarithmic 
relationship to the inner mitochondrial membrane 
potential (Verburg & Hollenbeck, 2008).
Quantifi cation of mitochondrial density in synaptic 
boutons. Samples exhibiting mitoGFP were stained 
with horseradish peroxidase (αHRP) and bruchpilot 
(αBRP) stains. αHRP highlights synaptic boutons 
while αBRP highlights calcium channels of nerve 
terminals to refl ect NMJ activity. Density was 
determined using hand-drawn polygonal ROI regions 
around clear synaptic boutons to fi nd the relative 
signal intensity of αHRP. This process was repeated 
to fi nd the relative signal intensity of mitoGFP. 
The two signal intensities were then compared 
in order to determine the integrated intensity of 
mitochondria within each bouton. This value served 
as a method to quantify mitochondrial density. 
Density determination was conducted using the 
Elements software.
RESULTS
Parkin Mutants Exhibit Normal Mitochondrial ∆ψm 
Control and park25 samples were stained with TMRM 
lipophilic fl uorescent cationic dye for 20 minutes 
before imaging. Figure 4 shows representative control 
and park25 images in NMJs at A4 SNs. Mitochondria 
in synaptic boutons were selected for quantifi cation. 
Samples were compared with a mitochondrial matrix/
nerve axon ratio of TMRM signal intensity ( ) in 
order to standardize the signal from the TMRM dye 
in comparison to mitochondrial intensity. Mean  
ratios from 197 mitochondria from 13 control and 159 
mitochondria from 12 park25 animals were collected, 
and a mean of means was calculated. From the 
results, it is clear that the  state of mitochondria in 
NMJs is normal in both control and mutants. The 
differences between control and park25 were not 
statistically signifi cant, indicated by the t-test p value 
of 0.2764 (Figure 5). p value > 0.05; data is not 
statistically signifi cant. 
Figure 2. Drosophila third instar larvae dissection. Pin the larvae and make an incision down its abdomen, opening gently to 
remove all intestines and fat. Make four small horizontal cuts to further open the body, revealing its intact VG and SNs. Image 
under a confocal microscope. Dissections must be conducted gently and within 20 minutes to ensure an in vivo system.
Figure 3. To observe Drosophila nervous systems in 
vivo, third instar larvae were collected, dissected, 
and prepared. All images were taken via confocal 
microscopy. In each sample, mitochondria were 
analyzed in NMJs of middle A4 axons of SNs.
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In Figure 5, the error bars indicate the mean ± 
standard error of the mean (SEM). In the total control 
mitochondria analyzed, the mean of means TMRM 
intensity was 17.32 ± 0.81. For park25, TMRM 
intensity was 19.09 ± 1.40. The error bar margins in 
both control and park25 show relatively consistent 
data across all mitochondria samples from the 
calculated mean. However, the p value of 0.2764 
indicates that the mean of means  ratios between 
control and park25 are too similar and do not have a 
statistically significant difference. This indicates that 
synaptic boutons in both control and park25 exhibit 
normal  states.
In order to determine whether there was a variance in 
the distribution of mitochondria between control and 
park25 and whether this contributed to the obtained 
 results, a two-sample Kolmogorov-Smirnov test 
was conducted (Figure 5). A side-by-side comparison 
of mitochondria in the synaptic boutons of control 
and park25 is shown on the bar graph. The test 
showed that there was no significant difference in the 
distribution of synaptic mitochondria between control 
and mutant animals. This validates the mean of 
means quantification method that was used for  
 analysis.
Park25 Animals Show Reduced Mitochondrial 
Density in Nerve Terminals
Samples exhibiting mitoGFP were additionally 
stained with αHRP and αBRP in order to further 
outline the synaptic boutons and quantify NMJ nerve 
activity. As shown in Figure 6, the three different 
stains on each control and park25 sample can be 
viewed separately from a superimposed image. 
Figure 7 shows representative density images for 
control and park25. The red circular outlines represent 
individual synaptic boutons; these were analyzed for 
mitochondrial density analyses. The entire synaptic 
bouton was selected, and the mitoGFP signal from 
within each synaptic bouton was selected as well. 
These two intensities of αHRP and mitoGFP were 
then compared by integrated intensity to determine 
the relative density of mitochondria present in the 
respective synaptic bouton. 
Figure 5. Quantitative analyses of  mean of means method showed that there is no significant difference in  states 
between control and mutant animals. Error bars indicate mean ± SEM. p value 0.2764 > 0.05; data is not statistically 
significant. Two-sample Kolmogorov-Smirnov test for potential differences in mitochondrial distribution between control 
and park25 shows no difference in distribution across all samples. One hundred ninety-seven mitochondria from 13 control 
animals and 159 mitochondria from 12 park25 animals were analyzed for  data.
Figure 4. Representative TMRM images for control 
and park25 in NMJs at A4 SNs. Mitochondria in synaptic 





itochondria in Parkinson’s D
isease
Journal of Purdue Undergraduate Research: Volume 6, Fall 201646
Density differences between control and park25 were 
found to be statistically different. However, instead 
of park25 exhibiting an increased mitochondrial 
density, they displayed a statistically significant 
decreased density in comparison to control synapses 
(Figure 8). Density was analyzed in 61 synaptic 
boutons from 9 control and 61 synaptic boutons from 
10 park25 animals. In control, synaptic boutons have 
approximately 44% coverage with mitochondria 
while park25 only has 30% coverage. Data indicates 
that mutants show reduced mitochondrial density. 
The t-test p value was also calculated to be < 0.001, 
indicating a clear statistical difference between 
control and park25.
DISCUSSION
Mitochondrial integrity plays a pivotal role in the 
normal functioning of neurons; therefore, defects 
in the mitochondrial life cycle are frequently 
associated with many diseases of the nervous 
system. But in most cases, it is still unclear which 
of these potential defects underlie these disorders, 
nor are the relationships between specific defective 
processes and neuropathology known. In this 
study, we modeled the neurodegenerative disease 
Parkinson’s, which is characterized by a progressive 
loss in muscle control. It is believed that one of 
the most frequent causes of Parkinson’s disease 
is the accumulation of dysfunctional or damaged 
mitochondria in the neurons, meaning that the 
pathogenesis of Parkinson’s may arise in part from 
the ineffective turnover of mitochondria (Winklhofer 
& Haass, 2010). A plethora of previous work (e.g., 
Ashrafi et al., 2014; Amiri & Hollenbeck, 2008; 
Rugarli & Langer, 2012; Schwarz, 2013) has studied 
the turnover of mitochondria in the CB and axons, 
but no work has been done to analyze mitophagy 
in the nerve terminals. We aimed to elucidate the 
mechanisms of Parkin in mitochondrial turnover 
in the NMJs in vivo in intact nervous systems of 
Drosophila.
Figure 6. Control and park25 samples exhibiting mitoGFP were also stained with αHRP and αBRP. The left-most neurons show 
the superimposed image of the three signals. αHRP highlights of the synaptic boutons were used for mitochondrial density 
quantification.
Figure 7. Representative density images for control and 
park25 animals.
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Mitochondria use their membrane potential for a 
variety of functions, such as the synthesis of ATP. 
Therefore, decreased  readings in mitochondria 
are associated with unhealthy mitochondria that will 
undergo turnover. In park25 mutant animals, which 
exhibited Parkin null expression, we expected to see 
disruption to the PINK1-Parkin mitophagy process. 
This, we believed, would cause the accumulation of 
senescent mitochondria in neurons. From this, we 
hypothesized that park25 NMJ mitochondria would 
exhibit overall deficient  states and increased 
mitochondrial density in comparison to 
control animals.
Results from  data seems to show that there is no 
statistical significance in  readings between 
control and park25 animals (Figures 4–5). This goes 
against our hypothesis, for we predicted that Parkin 
null mutants would exhibit accumulation of senescent 
mitochondria in nerve terminals. However, as 
indicative from our results, this does not appear to be 
the case. The density results further show that 
mitochondria are not accumulating within neurons, 
for park25 exhibited overall decreased mitochondrial 
density within synaptic boutons (Figures 6–8).
From our results, we believe that there is a “barrier” 
of some sort between the CB and the axon that is 
selectively permeable only to healthy mitochondria; 
this is consistent with previous findings that the 
majority of mitochondria in axons seemed to exhibit 
normal physiological states, and that there were 
noticeably fewer mitochondria in axons than CBs. As 
mitochondria are mostly synthesized in the CB to be 
shipped out to the rest of the neurons, the proposed 
hypothesis appears consistent with this finding as 
well. Or, here is a potential second mechanism for 
how the obtained results are possible; unhealthy 
mitochondria may be anterogradely shipped to the 
cell body for turnover. If the mitochondria are 
shipped out of the synaptic boutons, our readings on 
normal  would indicate that we only measured the 
membrane potentials of the remaining, healthy 
mitochondria. And since mitochondria would be 
returning to the CB, there would be reduced 
density as well.
Essentially, we believe that there are two possible 
explanations for our results of normal  but 
reduced density in park25 animals. (1) There is a 
“barrier” between the CB and axon that is only 
permeable to healthy mitochondria, or (2) unhealthy 
mitochondria may be anterogradely shipped to the 
CB for turnover. Potential future studies could aim to 
elucidate the proposed mechanisms further by 
utilizing αBRP to quantify nerve activity. While 
implicated to play an important role in the 
mitochondrial life cycle, the role of Parkin still 
widely remains unknown.
REFERENCES
Amiri M., & Hollenbeck, P. J. (2008). Mitochondrial 
biogenesis in the axons of vertebrate peripheral neurons. 
Developmental Neurobiology, 68, 1348–1361.
Ashrafi, G., Schlehe, J. S., LaVoie, M. J., & Schwarz, T. L. 
(2014). Mitophagy of damaged mitochondria occurs 
locally in distal neuronal axons and requires PINK1 and 
Parkin. Journal of Cell Biology, 206, 655–670.
Devireddy, S., Liu, A., Lampe, T., & Hollenbeck, P. J. (2015). 
The organization of mitochondrial quality control and 
life cycle in the nervous system in vivo in the absence of 
PINK1. Journal of Neuroscience: The Official Journal of 
the Society for Neuroscience, 35, 9391–9401.
Devireddy, S., Sung, H., Liao, P. C., Garland-Kuntz, E., & 
Hollenbeck, P. J. (2014). Analysis of mitochondrial 
traffic in Drosophila. Methods in Enzymology, 547, 
131–150.
Geisler, S., Holmstrom, K. M., Skujat, D., Fiesel, F. C., 
Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010). 
PINK1/Parkin-mediated mitophagy is dependent on 
VDAC1 and p62/SQSTM1. Nature Cell Biology, 12, 
119–131.
Jin, S. M., & Youle, R. J. (2012). PINK1- and Parkin-
mediated mitophagy at a glance. Journal of Cell Science, 
125, 795–799.
Narendra, D., Walker, J. E., & Youle, R. J. (2012). 
Mitochondrial quality control mediated by PINK1 and 
parkin: Links to parkinsonism. Cold Spring Harbor 
Perspectives in Biology, 4.
Figure 8. Density differences between synaptic bouton 
mitochondria of control and park25 are statistically 
significant. Error bars indicate mean ± SEM. p value  
< 0.001, data is statistically significant. In control 44% 
of synaptic boutons are covered by mitochondria while 
park25 has 30% coverage. Sixty-one boutons from  






itochondria in Parkinson’s D
isease
Journal of Purdue Undergraduate Research: Volume 6, Fall 201648
Okamoto, K., & Shaw, J. M. (2005). Mitochondrial morphology 
and dynamics in yeast and multicellular eukaryotes. 
Annual Review of Genetics, 39, 503–536.
Rubinsztein, D. C., Shpilka, T., & Elazar, Z. (2012). 
Mechanisms of autophagosome biogenesis. Current 
Biology, 22, R29–34.
Rugarli, E. I., & Langer, T. (2012). Mitochondrial quality 
control: A matter of life and death for neurons. The EMBO 
Journal, 31, 1336–1349.
Schwarz, T. L. (2013). Mitochondrial trafficking in neurons. 
Cold Spring Harbor Perspectives in Biology, 5.
Shidara, Y., & Hollenbeck, P. J. (2010). Defects in 
mitochondrial axonal transport and membrane potential 
without increased reactive oxygen species production 
in a Drosophila model of Friedreich ataxia. Journal of 
Neuroscience: The Official Journal of the Society for 
Neuroscience, 30, 11369–11378.
Terman, A., Kurz, T., Navratil, M., Arriaga, E. A., & Brunk, 
U. T. (2010). Mitochondrial turnover and aging of long-lived 
postmitotic cells: The mitochondrial-lysosomal axis theory of 
aging. Antioxidants & Redox Signaling, 12, 503–535.
Verburg, J., & Hollenbeck, P. J. (2008). Mitochondrial 
membrane potential in axons increases with local nerve 
growth factor or semaphorin signaling. Journal of 
Neuroscience: The Official Journal of the Society for 
Neuroscience, 28, 8306–8315.
Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., 
Selkoe, D., . . .Schwarz, T. L. (2011). PINK1 and Parkin 
target Miro for phosphorylation and degradation to arrest 
mitochondrial motility. Cell, 147, 893–906.
Winklhofer, K. F., & Haass, C. (2010). Mitochondrial 
dysfunction in Parkinson’s disease. Biochimica et 
Biophysica Acta, 1802, 29–44.
Yang, Y., Ouyang, Y., Yang, L., Beal, M. F., McQuibban, A., 
Vogel, H., & Lu, B. (2008). Pink1 regulates mitochondrial 
dynamics through interaction with the fission/fusion 
machinery. Proceedings of the National Academy of 
Sciences of the United States of America, 105, 7070–7075.
